Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: An experimental study

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 908-914

  Sagiroglu, Tamer ^a   Torun, Nese ^a   Yagci, Mehmet ^b   Yalta, Tülin ^a   Sagiroglu, Gönül ^a   Oguz, Serhat ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Hakkari State Hospital   (Turkey)

Author keywords

Apelin; Leptin; Renal ischemia reperfusion

Indexed keywords

APELIN; CREATININE; LEPTIN; POTASSIUM; PROTEIN; SODIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL STUDY; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NONHUMAN; RAT; RENAL PROTECTION; REPERFUSION INJURY;

EID: 84858690255     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.499     Document Type: Article

References (28)

1. Carden DL and Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 190: 255-266, 2000.
2. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376: 1-43, 2007.
3. Li MD: Leptin and beyond: an odyssey to the central control of body weight. Yale J Biol Med 84: 1-7, 2011.
4. Cao R, Brakenhielm E, Wahlestedt C, et al: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98: 6390-6395, 2001.
5. Wolf G, Hamann A, Han DC, et al: Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 56: 860-872, 1999.
6. Mastronardi CA, Yu WH and McCann SM: Resting and circadian release of nitric oxide is controlled by leptin in male rats. Proc Natl Acad Sci USA 99: 5721-5726, 2002.
7. Lin J, Yan GT, Wang LH, et al: Leptin fluctuates in intestinal ischemia-reperfusion injury as inflammatory cytokine. Peptides 25: 2187-2193, 2004.
8. Shi Y, Yan GT, Lin J, et al: Intestinal ischemia-reperfusion injury made leptin decreased. Regul Pept 133: 27-31, 2006.
9. Kleinz MJ and Davenport AP: Emerging roles of apelin in biology and medicine. Pharmacol Ther 107: 198-211, 2005.
10. Hacioglu A, Algin C, Pasaoglu O, et al: Protective effect of leptin against ischemia-reperfusion injury in the rat small intestine. BMC Gastroenterol 5: 37, 2005.
11. Pan CS, Teng X, Zhang J, et al: Apelin antagonizes myocardial impairment in sepsis. J Card Fail 16: 609-617, 2010.
12. Kaya H, Balci TA, Cobaner A, et al: Evaluation on the renal tubular damage in rats with acute haemorrhagic hypovolemic shock using Tc-99m DMSA uptake scintigraphy. Turk J Nucl Med 12: 85-89, 2003.
13. Parra C, Salas P and Dominguez J: Effects of immunosuppressive drugs on rat renal ischemia reperfusion injury. Transplant Proc 42: 245-247, 2010.
14. Yamamoto S, Hagiwara S, Hidaka S, et al: The antioxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol 33: 485-490, 2011.
15. Koga H, Hagiwara S, Kusaka J, et al: Human atrial natriuretic peptide attenuates renal ischemia-reperfusion injury. J Surg Res: Nov 4, 2010. (Epub ahead of print)
16. Medeiros PJ, Villarim Neto A, Lima FP, et al: Effect of sildenafil in renal ischemia/reperfusion injury in rats. Acta Cir Bras 25: 490-495, 2010.
17. Prókai A, Fekete A, Bánki NF, et al: Renoprotective effect of erythropoietin in rats subjected to ischemia/reperfusion injury: gender differences. Surgery 150: 39-47, 2011.
18. Regner KR, Nilakantan V, Ryan RP, et al: Protective effect of Lifor solution in experimental renal ischemia-reperfusion injury. J Surg Res 164: 291-297, 2010.
19. Zhang L, Huang H, Cheng J, et al: Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice. Life Sci 88: 1102-1107, 2011.
20. Vianna PT, Castiglia YM, Braz JR, et al: Remifentanil, isoflurane, and preconditioning attenuate renal ischemia/reperfusion injury in rats. Transplant Proc 41: 4080-4082, 2009.
21. Simpkin JC, Yellon DM, Davidson SM, et al: Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 102: 518-528, 2007.
22. Zeng XJ, Zhang LK, Wang HX, et al: Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30: 1144-1152, 2009.
23. Malyszko J, Malyszko JS, Pawlak K, et al: Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc 40:3466-3469, 2008.
24. Kunduzova O, Alet N, Delesque-Touchard N, et al: Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes. FASEB J 22: 4146-4153, 2008.
25. Malyszko J, Malyszko JS, Pawlak K, et al: Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure. Adv Med Sci 53: 32-36, 2008.
26. Principe A, Melgar-Lesmes P, Fernández-Varo G, et al: The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 48: 1193-1201, 2008.
27. Sukhotnik I, Helou H, Lurie M, et al: The effect of leptin on intestinal recovery following ischemia-reperfusion injury in a rat. Pediatr Surg Int 23: 473-478, 2007.
28. Hus-Citharel A, Bouby N, Frugière A, et al: Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 74: 486-494, 2008.